Sharon Walsh

Research interests

Publications

• Signal of increased opioid overdose during COVID-19 from emergency medical services data

  Drug and Alcohol Dependence · 2020 · https://doi.org/10.1016/j.drugalcdep.2020.108176

• Opioid use disorder

  Nature Reviews Disease Primers · 2020 · https://doi.org/10.1038/s41572-019-0137-5

• Cannabidiol: pharmacology and therapeutic targets

  Psychopharmacology · 2020 · 10.1007/s00213-020-05712-8

• The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

  Drug and Alcohol Dependence · 2020 · 10.1016/j.drugalcdep.2020.108335

• Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

  Journal of Addiction Medicine · 2018 · 10.1097/adm.0000000000000457

• Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

  JAMA Internal Medicine · 2018 · 10.1001/jamainternmed.2018.1052

• A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

  Drug and Alcohol Dependence · 2017 · 10.1016/j.drugalcdep.2017.04.020

• Gabapentin misuse, abuse and diversion: a systematic review

  Addiction · 2016 · 10.1111/add.13324

• Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

  Drug and Alcohol Dependence · 2016 · 10.1016/j.drugalcdep.2016.11.030

• Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis

  Neuropsychopharmacology · 2015 · 10.1038/npp.2015.367

• Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm Society

  Journal of Pain · 2014 · 10.1016/j.jpain.2014.01.494

• A Review of Buprenorphine Diversion and Misuse

  Journal of Addiction Medicine · 2014 · 10.1097/adm.0000000000000045

• Neuropsychopharmacology

  Journal · 2010 · https://doi.org/10.1007/978-3-540-68706-1_4410

• The role of human drug self-administration procedures in the development of medications

  Drug and Alcohol Dependence · 2008 · 10.1016/j.drugalcdep.2008.03.001

• The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers

  Drug and Alcohol Dependence · 2008 · 10.1016/j.drugalcdep.2008.05.007

• The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic

  Drug and Alcohol Dependence · 2003 · 10.1016/s0376-8716(03)00056-5

• Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans

  Psychopharmacology · 2001 · 10.1007/s002130000624

• Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

  Psychopharmacology · 2001 · 10.1007/s002130100788

• Effects of buprenorphine/naloxone in opioid-dependent humans

  Psychopharmacology · 2001 · 10.1007/s002130000637

• A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence

  New England Journal of Medicine · 2000 · https://doi.org/10.1056/nejm200011023431802

• Elimination of Cocaine and Metabolites in Plasma, Saliva, and Urine Following Repeated Oral Administration to Human Volunteers

  Journal of Analytical Toxicology · 2000 · 10.1093/jat/24.7.467

• Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine

  Psychopharmacology · 1997 · 10.1007/s002130050210

• Acute administration of buprenorphine in humans: partial agonist and blockade effects.

  Journal of Pharmacology and Experimental Therapeutics · 1995 · 10.1016/s0022-3565(25)10510-7

• Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists

  Controlled Clinical Trials · 1995 · https://doi.org/10.1016/0197-2456(94)00031-w

• Clinical pharmacology of buprenorphine: Ceiling effects at high doses

  Clinical Pharmacology & Therapeutics · 1994 · https://doi.org/10.1038/clpt.1994.71

Current projects

No projects listed.